GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medistim A MEDI.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

319.00

+4.25%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NOK, from our data supplier.

FY2025

Revenue

NOK 699.8m

FY2016FY2025

Net income

NOK 159.2m

FY2016FY2025

Free cash flow

NOK 158.6m

FY2016FY2025

Shareholders' equity

NOK 468.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueNOK 699.8mNOK 562.6mNOK 526.4mNOK 491.9mNOK 417.8mNOK 356.2mNOK 356.9mNOK 323.0mNOK 296.1mNOK 262.7m
Gross profitNOK 571.6mNOK 448.9mNOK 414.1mNOK 385.5mNOK 320.7mNOK 279.6mNOK 276.8mNOK 243.6mNOK 223.3mNOK 197.7m
Operating incomeNOK 196.2mNOK 131.1mNOK 131.4mNOK 141.3mNOK 116.3mNOK 95.5mNOK 91.5mNOK 75.0mNOK 67.1mNOK 56.4m
Net incomeNOK 159.2mNOK 103.8mNOK 103.8mNOK 114.0mNOK 90.9mNOK 69.4mNOK 70.3mNOK 57.1mNOK 47.6mNOK 39.1m
Diluted earnings per share8.715.675.686.242.243.813.863.132.612.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsNOK 660.6mNOK 575.0mNOK 505.7mNOK 482.7mNOK 403.2mNOK 345.8mNOK 336.1mNOK 269.6mNOK 251.1mNOK 217.0m
Cash and short-term investments—NOK 171.3mNOK 146.1mNOK 144.2mNOK 124.9mNOK 65.8mNOK 62.4mNOK 43.5mNOK 50.6mNOK 28.2m
Total liabilitiesNOK 192.2mNOK 138.4mNOK 107.8mNOK 115.0mNOK 97.2mNOK 89.0mNOK 99.2mNOK 62.9mNOK 68.1mNOK 50.3m
Debt—NOK 34.4mNOK 17.6mNOK 17.1mNOK 24.2mNOK 39.1mNOK 36.4mNOK 10.5mNOK 15.4mNOK 5.6m
Shareholders' equityNOK 468.4mNOK 436.6mNOK 397.9mNOK 367.7mNOK 306.1mNOK 256.8mNOK 236.9mNOK 206.7mNOK 183.0mNOK 166.7m
Shares outstanding18m18m18m18m41m18m18m18m18m18m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsNOK 191.6mNOK 143.1mNOK 113.2mNOK 114.6mNOK 128.1mNOK 74.1mNOK 80.4mNOK 55.8mNOK 60.1mNOK 30.5m
Capital spending−NOK 33.0m−NOK 24.7m−NOK 29.7m−NOK 9.3m−NOK 11.5m−NOK 10.6m−NOK 13.7m−NOK 16.4m−NOK 14.5m−NOK 13.5m
Free cash flowNOK 158.6mNOK 118.4mNOK 83.5mNOK 105.3mNOK 116.7mNOK 63.5mNOK 66.7mNOK 39.4mNOK 45.6mNOK 17.0m
Dividends paid−NOK 109.5m−NOK 82.4m−NOK 82.2m−NOK 68.4m−NOK 54.6m−NOK 50.1m−NOK 40.9m−NOK 36.4m−NOK 31.8m−NOK 29.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueNOK 202.0mNOK 201.7mNOK 182.3mNOK 166.8mNOK 169.1mNOK 181.5mNOK 151.1mNOK 132.8m
Gross profitNOK 166.1mNOK 160.4mNOK 146.2mNOK 136.0mNOK 138.4mNOK 151.0mNOK 117.6mNOK 106.6m
Operating incomeNOK 65.3mNOK 57.1mNOK 48.9mNOK 40.6mNOK 54.1mNOK 59.2mNOK 25.8mNOK 31.9m
Net incomeNOK 52.2mNOK 40.3mNOK 38.1mNOK 34.7mNOK 43.0mNOK 43.4mNOK 21.3mNOK 23.4m
Diluted earnings per share2.862.202.081.902.352.381.161.28
Cash from operationsNOK 47.0mNOK 7.0mNOK 191.0mNOK 125.0mNOK 56.0mNOK 18.0mNOK 143.0mNOK 77.0m
Total assetsNOK 581.9mNOK 681.9mNOK 660.6mNOK 575.2mNOK 535.0mNOK 617.3mNOK 575.0mNOK 491.0m
Cash and short-term investments——NOK 212.1mNOK 157.7mNOK 96.4mNOK 183.4mNOK 179.2mNOK 127.3m
Debt——NOK 37.5mNOK 21.3mNOK 22.0mNOK 26.2mNOK 25.1mNOK 7.5m
Shareholders' equityNOK 411.0mNOK 506.7mNOK 468.4mNOK 418.6mNOK 383.8mNOK 466.4mNOK 436.6mNOK 405.1m

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin81.7%79.8%78.7%78.4%76.8%78.5%———
Operating margin30.4%23.3%25.0%28.7%27.3%25.8%———
Net margin22.8%18.5%19.7%23.2%21.8%19.5%———
Return on equity34.0%23.8%26.1%31.0%29.7%27.0%———
Return on assets24.1%18.1%20.5%23.6%22.5%20.1%———
Free cash flow yield———2.4%1.2%1.6%1.8%1.4%1.4%
Revenue growth24.4%6.9%7.0%17.7%17.3%-0.2%———
Earnings growth53.3%0.0%-8.9%25.4%31.0%-1.3%———
Current ratio3.34x4.00x4.15x3.87x3.95x4.13x———
Debt to equity—0.00x0.00x0.00x0.02x0.07x0.06x——
Equity ratio70.9%75.9%78.7%76.2%75.9%74.3%———
Interest coverage34.20x267.50x870.48x1148.38x641.85x628.45x———
Buybacks as a share of market value———55.0%-123.1%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.5%14.5%10.8%
Operating income11.6%15.5%14.0%
Net income11.8%18.1%14.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin80.8%79.8%79.2%78.1%
Operating margin25.9%26.3%26.6%25.4%
Net margin20.8%21.1%21.0%19.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings29.726.437.737.0164.265.649.722.627.634.2
Price to sales6.84.97.48.635.712.89.84.04.45.1

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 7 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year8.006.004.504.503.753.002.752.25

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.